331 research outputs found
Item-Level Scores on the Boston Naming Test as an Independent Predictor of Perirhinal Volume in Individuals with Mild Cognitive Impairment
We explored the methodological value of an item-level scoring procedure applied to the Boston Naming Test (BNT), and the extent to which this scoring approach predicts grey matter (GM) variability in regions that sustain semantic memory. Twenty-seven BNT items administered as part of the Alzheimer’s Disease Neuroimaging Initiative were scored according to their “sensorimotor interaction” (SMI) value. Quantitative scores (i.e., the count of correctly named items) and qualitative scores (i.e., the average of SMI scores for correctly named items) were used as independent predictors of neuroanatomical GM maps in two sub-cohorts of 197 healthy adults and 350 mild cognitive impairment (MCI) participants. Quantitative scores predicted clusters of temporal and mediotemporal GM in both sub-cohorts. After accounting for quantitative scores, the qualitative scores predicted mediotemporal GM clusters in the MCI sub-cohort; clusters extended to the anterior parahippocampal gyrus and encompassed the perirhinal cortex. This was confirmed by a significant yet modest association between qualitative scores and region-of-interest-informed perirhinal volumes extracted post hoc. Item-level scoring of BNT performance provides complementary information to standard quantitative scores. The concurrent use of quantitative and qualitative scores may help profile lexical–semantic access more precisely, and might help detect changes in semantic memory that are typical of early-stage Alzheimer’s disease
IC‐P‐196: ADVANCING THE ACCURACY OF AUTOMATED FDG‐PET MEASUREMENTS USING HIGH‐DIMENSIONAL IMAGE NORMALIZATION
Machine Learning for Alzheimer’s Disease and Related Dementias
Dementia denotes the condition that affects people suffering from cognitive and behavioral impairments
due to brain damage. Common causes of dementia include Alzheimer’s disease, vascular dementia, or
frontotemporal dementia, among others. The onset of these pathologies often occurs at least a decade
before any clinical symptoms are perceived. Several biomarkers have been developed to gain a better insight
into disease progression, both in the prodromal and the symptomatic phases. Those markers are commonly
derived from genetic information, biofluid, medical images, or clinical and cognitive assessments. Information is nowadays also captured using smart devices to further understand how patients are affected. In the
last two to three decades, the research community has made a great effort to capture and share for research a
large amount of data from many sources. As a result, many approaches using machine learning have been
proposed in the scientific literature. Those include dedicated tools for data harmonization, extraction of
biomarkers that act as disease progression proxy, classification tools, or creation of focused modeling tools
that mimic and help predict disease progression. To date, however, very few methods have been translated
to clinical care, and many challenges still need addressing
Looking beneath the surface: the importance of subcortical structures in frontotemporal dementia.
Funder: National Institute for Health Research (NIHR) Queen Square Dementia Biomedical Research UnitFunder: Alzheimer's Research UK, Brain Research Trust and The Wolfson FoundationFunder: Medical Research CouncilFunder: Alzheimer’s Society and Alzheimer’s Research UKFunder: NIHR UCL/H Biomedical Research Centre and the Leonard Wolfson Experimental Neurology Centre (LWENC) Clinical Research FacilityFunder: DRI LtdWhilst initial anatomical studies of frontotemporal dementia focussed on cortical involvement, the relevance of subcortical structures to the pathophysiology of frontotemporal dementia has been increasingly recognized over recent years. Key structures affected include the caudate, putamen, nucleus accumbens, and globus pallidus within the basal ganglia, the hippocampus and amygdala within the medial temporal lobe, the basal forebrain, and the diencephalon structures of the thalamus, hypothalamus and habenula. At the most posterior aspect of the brain, focal involvement of brainstem and cerebellum has recently also been shown in certain subtypes of frontotemporal dementia. Many of the neuroimaging studies on subcortical structures in frontotemporal dementia have been performed in clinically defined sporadic cases. However, investigations of genetically- and pathologically-confirmed forms of frontotemporal dementia are increasingly common and provide molecular specificity to the changes observed. Furthermore, detailed analyses of sub-nuclei and subregions within each subcortical structure are being added to the literature, allowing refinement of the patterns of subcortical involvement. This review focuses on the existing literature on structural imaging and neuropathological studies of subcortical anatomy across the spectrum of frontotemporal dementia, along with investigations of brain-behaviour correlates that examine the cognitive sequelae of specific subcortical involvement: it aims to 'look beneath the surface' and summarize the patterns of subcortical involvement have been described in frontotemporal dementia
O5‐04‐05: Morphological differences in the striatum in early and late‐onset Alzheimer's disease
IC‐P‐037: Morphological differences in the striatum in early‐ and late‐onset Alzheimer's disease
Characterising the spatiotemporal heterogeneity of neurodegenerative diseases using subtype and stage inference
[IC‐P‐052]: SQSTM1 MUTATIONS IN FRONTOTEMPORAL DEMENTIA ARE ASSOCIATED WITH ASYMMETRICAL FOCAL TEMPORAL LOBE ATROPHY
IC‐P‐016: Is The Incremental Diagnostic Value of Amyloid‐Pet Affected by Information on Other Core Biomarkers?
P4–345: Providing standardized labels of the EADC‐ADNI Harmonized Hippocampal Protocol for automated algorithm training
- …